ABT belongs to the non-nuc club. This might force others try non-nuc combinations like ABT does.
My opinion remains as before, all oral combination for hep c will have twist and turn, GILD included. I think it is going to take much longer than most people think, whether it is safety, or efficacy (viral breakthrough etc).
Market Data 
Markets 
AI
